Traphaco Joint Stock Company
Traphaco Joint Stock Company, commonly referred to as Traphaco, is a leading pharmaceutical enterprise headquartered in Vietnam. Established in 1972, the company has made significant strides in the healthcare sector, particularly in the production and distribution of herbal medicines and dietary supplements. With a strong operational presence across major regions in Vietnam, Traphaco is renowned for its commitment to quality and innovation. The company’s core offerings include a diverse range of herbal products, pharmaceuticals, and functional foods, distinguished by their adherence to traditional medicine principles combined with modern scientific research. Traphaco has achieved notable recognition in the market, positioning itself as a trusted brand in the Vietnamese pharmaceutical industry. Its dedication to sustainable practices and community health further solidifies its reputation as a pioneer in the sector.
DitchCarbon Score
How does Traphaco Joint Stock Company's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Traphaco Joint Stock Company's score of 22 is lower than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Traphaco Joint Stock Company's reported carbon emissions
Traphaco Joint Stock Company, headquartered in Vietnam, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures. The company has not established documented reduction targets or commitments to the Science Based Targets initiative (SBTi) or other climate pledges. As there are no emissions data or reduction initiatives available, it is unclear how Traphaco is addressing its carbon footprint or contributing to climate action within the pharmaceutical industry. The lack of reported emissions and targets suggests an opportunity for the company to enhance its climate strategy and transparency in line with industry standards.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Traphaco Joint Stock Company is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
